Rescue experimental results exhibited that suppressing miR-125a-5p impaired the inhibitory effects of ATOR on glioma cells, while overexpressing TXLNA enhanced the effects of suppressing miR-125a-5p on glioma cells. The gene discussed is TXLNA; the disease is central nervous system cancer.